Connect to other sites within the UBM Medica Network
The HPV 16/18 vaccine protects women from cervical, anal, and oral HPV infections that can lead to cancer, including some women previously exposed to HPV. Image © Jes2u.photo / Shutterstock.com.
Increased Risk of Second Malignancies With Radioactive Iodine Therapy for Thyroid Cancer
A new population-based study has found that patients with thyroid cancer who are treated with radioactive iodine therapy are at increased risk for developing salivary cancer as a second malignancy.
HPV Vaccine Can Protect Previously Exposed Patients
The HPV 16/18 vaccine protects women from cervical, anal, and oral HPV infections that can lead to cancer, including some women previously exposed to HPV.
Vaccinating Boys Against HPV Proves Cost-Effective
Vaccinating boys aged 12 years against the human papillomavirus (HPV) may be cost-effective in the prevention of oropharyngeal cancer.
Older Men at Higher Risk of Persistent Oral HPV Infection
An infection with oral HPV16 is likely to last for a year or longer in older men, putting them at higher risk for the development oropharyngeal cancer.
Smoking May Increase Risk of Second Primary Cancer
Cancer survivors are at an increased risk for developing a second smoking-associated cancer if they smoked cigarettes prior to their first cancer diagnosis.
Tobacco Use Tied to Oral Cancer–Causing HPV
Using tobacco is linked to an increased risk of infection with oral HPV type 16, a sexually transmitted virus known to cause cancers of the mouth and throat.
Afatinib Delayed Progression of Recurrent Head and Neck Cancer
In patients with recurrent or metastatic head and neck squamous cell carcinoma, afatinib better delayed cancer progression compared with methotrexate, according to results presented at the 2014 ESMO Congress.
By clicking Accept, you agree to become a member of the UBM Medica Community.